HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1.

Abstract
Herpes simplex virus 1 (HSV-1) and varicella-zoster virus (VZV) cause serious central nervous system (CNS) diseases that are diagnosed with PCR using samples of cerebrospinal fluid (CSF) and, during later stages of such infections, with assays of intrathecal IgG antibody production. However, serological diagnoses have been hampered by cross-reactions between HSV-1 and VZV IgG antibodies and are commonly reported in patients with herpes simplex encephalitis (HSE). In this study we have evaluated VZV glycoprotein E (gE) as a new antigen for serological diagnosis of VZV-induced CNS infections. Paired samples of CSF and serum from 29 patients with clinical diagnosis of VZV CNS infection (n = 15) or HSE (n = 14), all confirmed by PCR, were analyzed. VZV gE and whole VZV were compared as antigens in enzyme-linked immunosorbent assays (ELISAs) for serological assays in which the CSF/serum sample pairs were diluted to identical IgG concentrations. With the gE antigen, none of the HSE patients showed intrathecal IgG antibodies against VZV, compared to those shown by 11/14 patients using whole-VZV antigen (P < 0.001). In the patients with VZV infections, significantly higher CSF/serum optical density (OD) ratios were found in the VZV patients using the VZV gE antigen compared to those found using the whole-VZV antigen (P = 0.001). These results show that gE is a sensitive antigen for serological diagnosis of VZV infections in the CNS and that this antigen was devoid of cross-reactivity to HSV-1 IgG in patients with HSE. We therefore propose that VZV gE can be used for serological discrimination of CNS infections caused by VZV and HSV-1.
AuthorsAnna Grahn, Marie Studahl, Staffan Nilsson, Elisabeth Thomsson, Malin Bäckström, Tomas Bergström
JournalClinical and vaccine immunology : CVI (Clin Vaccine Immunol) Vol. 18 Issue 8 Pg. 1336-42 (Aug 2011) ISSN: 1556-679X [Electronic] United States
PMID21697341 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
  • Viral Envelope Proteins
  • glycoprotein E, varicella-zoster virus
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral (cerebrospinal fluid)
  • Child, Preschool
  • Clinical Laboratory Techniques (methods)
  • Encephalitis, Varicella Zoster (diagnosis, immunology)
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Female
  • Herpesvirus 1, Human (immunology)
  • Herpesvirus 3, Human (immunology)
  • Humans
  • Immunoglobulin G (cerebrospinal fluid)
  • Male
  • Middle Aged
  • Sensitivity and Specificity
  • Viral Envelope Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: